Bellicum Pharmaceuticals announces closing of $69.0 million public offering
Bellicum announced the closing of its underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant underwriters’ full exercise of their option to purchase additional shares, at a public offering price of $7.50 per share. April 20, 2018